Leukocyte perturbation associated with Fabry disease

Author： Rozenfeld P.   Agriello E.   Francesco N.   Martinez P.   Fossati C.  

Publisher： Springer Publishing Company

ISSN： 0141-8955

Source： Journal of Inherited Metabolic Disease, Vol.32, Iss.1, 2009-12, pp. : 67-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal disease in Fabry patients

By Grünfeld J.-P.   Lidove O.   Joly D.   Barbey F.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 71-74

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for Fabry disease

By Sitaskas C.   Medin J.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 25-41

Springer Publishing Company

Access to resources Recommend Favorite

Cardiac manifestations in Fabry disease

By Linhart A.   Lubanda J.-C.   Palecek T.   Bultas J.   Karetová D.   Ledvinová J.   Elleder M.   Aschermann M.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 75-83

Springer Publishing Company

Access to resources Recommend Favorite

An historical overview of Fabry disease

By Fabry H.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 3-7

Springer Publishing Company

Access to resources Recommend Favorite

A modified lipid composition in Fabry disease leads to an intracellular block of the detergent-resistant membrane-associated dipeptidyl peptidase IV

By Maalouf Katia   Jia Jia   Rizk Sandra   Brogden Graham   Keiser Markus   Das Anibh   Naim Hassan  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 4, 2010-08 ,pp. : 445-449

Springer Publishing Company

Access to resources Recommend Favorite